XML 36 R39.htm IDEA: XBRL DOCUMENT v3.2.0.727
Segment Information (Tables)
12 Months Ended
Jun. 30, 2015
Segment Reporting Information [Line Items]  
Revenue by Reportable Segment
The following tables present revenue for each reportable segment and Corporate:
(in millions)
2015
 
2014
 
2013
Pharmaceutical (1)
$
91,116

 
$
80,110

 
$
91,097

Medical
11,395

 
10,962

 
10,060

Total segment revenue
102,511

 
91,072

 
101,157

Corporate (2)
20

 
12

 
(64
)
Total revenue
$
102,531

 
$
91,084

 
$
101,093


(1)
Our pharmaceutical distribution contract with Walgreen Co. expired on August 31, 2013.
(2)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment
The following tables present segment profit by reportable segment and Corporate:
(in millions)
2015
 
2014
 
2013
Pharmaceutical
$
2,094

 
$
1,745

 
$
1,734

Medical
433

 
444

 
372

Total segment profit
2,527

 
2,189

 
2,106

Corporate
(366
)
 
(304
)
 
(1,110
)
Total operating earnings
$
2,161

 
$
1,885

 
$
996

Assets by Reportable Segment
The following table presents total assets for each reportable segment and Corporate at June 30:
(in millions)
2015
 
2014
 
2013
Pharmaceutical
$
17,385

 
$
15,361

 
$
16,258

Medical
7,095

 
6,768

 
6,521

Corporate
5,662

 
3,904

 
3,040

Total assets
$
30,142

 
$
26,033

 
$
25,819

Schedule of Revenue and Property and Equipment, net by Geographical Areas
The following tables present revenue and property and equipment, net by geographic area:
(in millions)
2015
 
2014
 
2013
United States
$
98,435

 
$
87,449

 
$
97,994

International
4,096

 
3,635

 
3,099

Total revenue
$
102,531

 
$
91,084

 
$
101,093

(in millions)
2015
 
2014
 
2013
United States
$
1,327

 
$
1,301

 
$
1,355

International
179

 
158

 
134

Property and equipment, net
$
1,506

 
$
1,459

 
$
1,489

Depreciation and Amortization by Segment  
Segment Reporting Information [Line Items]  
Schedule of Other Significant Items by Segments
The following tables present depreciation and amortization and additions to property and equipment by reportable segment and
at Corporate:
(in millions)
2015
 
2014
 
2013
Pharmaceutical
$
124

 
$
128

 
$
125

Medical
119

 
130

 
137

Corporate
208

 
201

 
135

Total depreciation and amortization
$
451

 
$
459

 
$
397

Additions to Property and Equipment by Segment  
Segment Reporting Information [Line Items]  
Schedule of Other Significant Items by Segments
(in millions)
2015
 
2014
 
2013
Pharmaceutical
$
90

 
$
72

 
$
46

Medical
87

 
72

 
48

Corporate
123

 
105

 
101

Total additions to property and equipment
$
300

 
$
249

 
$
195